冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300238 冠昊生物

已收盘 02-05 15:00:00

{"stockData":{"symbol":"300238","market":"SZ","secType":"STK","nameCN":"冠昊生物","latestPrice":15.55,"timestamp":1770274989000,"preClose":15.73,"halted":0,"volume":4766000,"delay":0,"changeRate":-0.0114,"floatShares":265000000,"shares":265000000,"eps":0.0992,"marketStatus":"已收盘","change":-0.18,"latestTime":"02-05 15:00:00","open":15.68,"high":15.83,"low":15.51,"amount":74513700,"amplitude":0.0203,"askPrice":15.56,"askSize":15,"bidPrice":15.55,"bidSize":276,"shortable":0,"etf":0,"ttmEps":0.0992,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"adjPreClose":15.73,"symbolType":"stock","openAndCloseTimeList":[[1770255000000,1770262200000],[1770267600000,1770274800000]],"highLimit":17.3,"lowLimit":14.16,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":265155701,"isCdr":false,"pbRate":7.29,"roa":"--","peRate":156.754032,"roe":"4.79%","epsLYR":0.1,"committee":0.79483,"marketValue":4123000000,"turnoverRate":0.018,"status":1,"floatMarketCap":4123000000},"requestUrl":"/m/hq/s/300238","defaultTab":"news","newsList":[{"id":"2609394394","title":"股市必读：冠昊生物(300238)股东户数3.07万户，较上期减少1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394394","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394394?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:42","pubTimestamp":1770226936,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，冠昊生物报收于15.73元，上涨0.32%，换手率1.84%，成交量4.89万手，成交额7652.95万元。来自股本股东变化：截至2026年1月30日，公司股东户数环比下降1.13%，户均持股上升至8646股，筹码集中度提升。股本股东变化股东户数变动近日冠昊生物披露，截至2026年1月30日公司股东户数为3.07万户，较1月20日减少351.0户，减幅为1.13%。户均持股数量由上期的8548.0股增加至8646.0股，户均持股市值为13.7万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0251","BK0086","300238","BK0077","BK0046"],"gpt_icon":0},{"id":"2608552413","title":"冠昊生物：截止2026年1月30日，公司股东总户数为30,667","url":"https://stock-news.laohu8.com/highlight/detail?id=2608552413","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608552413?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:06","pubTimestamp":1770192368,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止1月31日公司股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2026年1月30日，公司股东总户数为30,667。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400024738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0251","BK0086","300238","BK0077","BK0046"],"gpt_icon":0},{"id":"2606263161","title":"股市必读：冠昊生物（300238）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263161","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263161?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:09","pubTimestamp":1769364551,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，冠昊生物报收于17.17元，上涨2.88%，换手率7.22%，成交量19.14万手，成交额3.32亿元。董秘最新回复投资者： 请问截止2025年1月10日股东人数是多少？截止2026年1月20日，公司股东总户数为31,018。感谢您的关注与支持！当日关注点来自交易信息汇总：1月23日主力资金净流入1016.42万元，显示主力对冠昊生物的积极布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600000963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0086","BK0251","BK0077","300238"],"gpt_icon":0},{"id":"2605200624","title":"冠昊生物：截止2026年1月20日股东总户数为31,018","url":"https://stock-news.laohu8.com/highlight/detail?id=2605200624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605200624?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:42","pubTimestamp":1769157736,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年1月10日股东人数是多少？冠昊生物回复：尊敬的投资者您好！截止2026年1月20日，公司股东总户数为31,018。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300025713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0077","300238","BK0251","BK0042"],"gpt_icon":0},{"id":"2604974961","title":"股市必读：冠昊生物（300238）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604974961","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604974961?lang=zh_cn&edition=full","pubTime":"2026-01-19 03:08","pubTimestamp":1768763288,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，冠昊生物报收于16.54元，下跌2.48%，换手率4.43%，成交量11.74万手，成交额1.94亿元。董秘最新回复投资者： 董秘您好。公司生物型硬脑（脊）膜补片目前主要适用于硬脑膜、硬脊膜缺损时的外科修补手术，公司业务详细情况请参见公司披露的定期报告。交易信息汇总资金流向1月16日主力资金净流出657.63万元；游资资金净流出1783.6万元；散户资金净流入2441.23万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300238","BK0251","BK0077","BK0086"],"gpt_icon":0},{"id":"2603950550","title":"冠昊生物：生物型硬脑膜补片适用于外科修补手术","url":"https://stock-news.laohu8.com/highlight/detail?id=2603950550","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603950550?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:03","pubTimestamp":1768546989,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)01月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好。请问公司的核心产品“生物型硬脑膜补片”，是否可用于侵入式脑部手术中硬脑膜的修补与脑脊液封堵？在目前前沿的植入式电极手术中，该补片是否具备临床修复价值？谢谢冠昊生物回复：尊敬的投资者您好！公司生物型硬脑（脊）膜补片目前主要适用于硬脑膜、硬脊膜缺损时的外科修补手术，公司业务详细情况请参见公司披露的定期报告。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600018767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0042","BK0251","BK0077","300238"],"gpt_icon":0},{"id":"2601875910","title":"冠昊生物：截止2025年12月31日股东总户数为27,775","url":"https://stock-news.laohu8.com/highlight/detail?id=2601875910","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601875910?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:03","pubTimestamp":1767776588,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至2025年12月底公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年12月31日，公司股东总户数为27,775。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700025642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300238","BK0077","BK0086","BK0042","BK0046"],"gpt_icon":0},{"id":"2601074363","title":"异动快报：冠昊生物（300238）1月5日11点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601074363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601074363?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:30","pubTimestamp":1767583841,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息，11点25分冠昊生物触及涨停板。其所属行业医疗器械目前上涨。领涨股为博拓生物。该股为脑科学，骨科材料，医疗器械概念热股，当日脑科学概念上涨12.93%，骨科材料概念上涨4.86%，医疗器械概念上涨4.7%。12月31日的资金流向数据方面，主力资金净流出761.25万元，占总成交额19.12%，游资资金净流入318.38万元，占总成交额8.0%，散户资金净流入442.88万元，占总成交额11.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500010978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0042","BK0251","300238","BK0077"],"gpt_icon":0},{"id":"2593488722","title":"冠昊生物：截止2025年12月19日股东总户数为28,105","url":"https://stock-news.laohu8.com/highlight/detail?id=2593488722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593488722?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:01","pubTimestamp":1766394064,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到12月19日收盘，最新的股东人数是多少，谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年12月19日，公司股东总户数为28,105。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200020337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300238","BK0046","BK0042","BK0077","BK0086"],"gpt_icon":0},{"id":"2591463612","title":"冠昊生物(300238)12月10日股东户数2.9万户，较上期减少2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591463612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591463612?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:47","pubTimestamp":1765792042,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2025年12月10日公司股东户数为2.9万户，较11月28日减少712.0户，减幅为2.4%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至12月10日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年11月28日至2025年12月10日，冠昊生物区间跌幅为5.65%，在此期间股东户数减少712.0户，减幅为2.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","BK0077","BK0086","BK0042","300238"],"gpt_icon":0},{"id":"2588702301","title":"冠昊生物：截至2025年11月28日股东总户数为29672","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702301","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588702301?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:48","pubTimestamp":1764636492,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至11月底公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月28日，公司股东总户数为29672。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0251","BK0077","BK0042","300238"],"gpt_icon":0},{"id":"2586623299","title":"冠昊生物：生物人工肝项目已完成临床前研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2586623299","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586623299?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:48","pubTimestamp":1764146892,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物11月26日在投资者关系平台上答复投资者关心的问题。公司相关项目研究正积极有序推进中，其中生物人工肝项目目前已完成临床前研究，正积极推动临床转化，后续公司将根据项目具体进展情况，严格按照监管规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600023516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0086","BK0046","BK0077","BK0042","BK0251"],"gpt_icon":0},{"id":"2585454009","title":"冠昊生物：截止2025年11月20日股东总户数为29645","url":"https://stock-news.laohu8.com/highlight/detail?id=2585454009","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585454009?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:23","pubTimestamp":1763972604,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到11月20日的最新股东人数是多少，谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月20日，公司股东总户数为29645。感谢您的关注与支持！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251124/31819338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0046","BK0086","300238","BK0042","BK0077"],"gpt_icon":0},{"id":"2583351821","title":"股市必读：冠昊生物(300238)股东户数2.96万户，较上期增加4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583351821","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583351821?lang=zh_cn&edition=full","pubTime":"2025-11-14 01:52","pubTimestamp":1763056336,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，冠昊生物报收于16.93元，下跌1.11%，换手率7.99%，成交量21.19万手，成交额3.56亿元。当日关注点来自交易信息汇总：11月13日主力资金净流出1878.86万元，散户资金净流入1688.01万元。股本股东变化股东户数变动近日冠昊生物披露，截至2025年11月10日公司股东户数为2.96万户，较10月31日增加1194.0户，增幅为4.2%。户均持股数量由上期的9328.0股减少至8952.0股，户均持股市值为14.56万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300238","BK0046","BK0251","BK0086"],"gpt_icon":0},{"id":"2583858086","title":"冠昊生物：截止2025年11月10日股东总户数为29620","url":"https://stock-news.laohu8.com/highlight/detail?id=2583858086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583858086?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:42","pubTimestamp":1762994534,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，截止到2025年11月10日公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月10日，公司股东总户数为29620。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","BK0086","BK0042","BK0077","300238"],"gpt_icon":0},{"id":"2580273140","title":"冠昊生物：截至2025年10月31日股东总户数为28426","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273140?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:09","pubTimestamp":1762218552,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至10月底公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年10月31日，公司股东总户数为28426。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","BK0046","300238","BK0086","BK0042"],"gpt_icon":0},{"id":"2578517931","title":"冠昊生物(300238.SZ)发布前三季度业绩，归母净利润2671.85万元，下降4.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578517931","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578517931?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:51","pubTimestamp":1761645110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，冠昊生物(300238.SZ)发布2025年三季度报告，该公司前三季度营业收入为2.93亿元，同比增长5.52%。归属于上市公司股东的净利润为2671.85万元，同比减少4.02%。归属于上市公司股东的扣除非经常性损益的净利润为2582.06万元，同比增长27.60%。基本每股收益为0.1元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300238"],"gpt_icon":0},{"id":"2577315980","title":"股市必读：冠昊生物(300238)股东户数2.85万户，较上期增加1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577315980","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577315980?lang=zh_cn&edition=full","pubTime":"2025-10-23 03:46","pubTimestamp":1761162371,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，冠昊生物报收于15.75元，上涨0.13%，换手率1.41%，成交量3.74万手，成交额5899.51万元。当日关注点来自交易信息汇总：10月22日主力资金净流入329.85万元，呈现资金主动介入迹象。股本股东变化股东户数变动近日冠昊生物披露，截至2025年10月20日公司股东户数为2.85万户，较10月10日增加332.0户，增幅为1.18%。户均持股数量由上期的9405.0股减少至9296.0股，户均持股市值为14.54万元。董秘最新回复投资者： 请问截止2025年10月20日，公司股东人数多少？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300003346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300238","BK0251","BK0077","BK0086"],"gpt_icon":0},{"id":"2577356939","title":"冠昊生物：截止2025年10月20日股东总户数为28525","url":"https://stock-news.laohu8.com/highlight/detail?id=2577356939","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577356939?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:06","pubTimestamp":1761120386,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年10月20日，公司股东人数多少？冠昊生物回复：尊敬的投资者您好！截止2025年10月20日，公司股东总户数为28525。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200024198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300238","BK0046","BK0042","BK0077","BK0086"],"gpt_icon":0},{"id":"2576300581","title":"股市必读：冠昊生物（300238）10月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576300581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576300581?lang=zh_cn&edition=full","pubTime":"2025-10-20 04:00","pubTimestamp":1760904045,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，冠昊生物报收于15.33元，下跌2.23%，换手率1.53%，成交量4.04万手，成交额6266.35万元。董秘最新回复投资者： 诺和诺德和武田制药都相继退出细胞疗法的研究，并关闭相关部门，据说是耗费时间和大量资本，但回报很难。当日关注点来自交易信息汇总：10月17日主力资金净流出211.41万元，游资资金净流入199.83万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0077","300238","BK0251","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770281640589,"stockEarnings":[{"period":"1week","weight":-0.0278},{"period":"1month","weight":-0.0535},{"period":"3month","weight":0.0355},{"period":"6month","weight":-0.1068},{"period":"1year","weight":0.3207},{"period":"ytd","weight":0.1357}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0236},{"period":"6month","weight":0.1285},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0336}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"冠昊生物科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"30667人(较上一季度减少1.13%)","perCapita":"8645股","listingDate":"2011-07-06","address":"广东省广州市黄埔区玉岩路12号","registeredCapital":"26515万元","survey":"　　冠昊生物科技股份有限公司的主营业务是再生医学材料及再生型医用植入器械研发、生产及销售。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、欣比克本维莫德乳膏。","listedPrice":18.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冠昊生物,300238,冠昊生物股票,冠昊生物股票老虎,冠昊生物股票老虎国际,冠昊生物行情,冠昊生物股票行情,冠昊生物股价,冠昊生物股市,冠昊生物股票价格,冠昊生物股票交易,冠昊生物股票购买,冠昊生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}